10494 related articles for article (PubMed ID: 14657558)
1. Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans.
Low KB; Ittensohn M; Luo X; Zheng LM; King I; Pawelek JM; Bermudes D
Methods Mol Med; 2004; 90():47-60. PubMed ID: 14657558
[No Abstract] [Full Text] [Related]
2. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.
Clairmont C; Lee KC; Pike J; Ittensohn M; Low KB; Pawelek J; Bermudes D; Brecher SM; Margitich D; Turnier J; Li Z; Luo X; King I; Zheng LM
J Infect Dis; 2000 Jun; 181(6):1996-2002. PubMed ID: 10837181
[TBL] [Abstract][Full Text] [Related]
3. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.
Agorio C; Schreiber F; Sheppard M; Mastroeni P; Fernandez M; Martinez MA; Chabalgoity JA
J Gene Med; 2007 May; 9(5):416-23. PubMed ID: 17410612
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy in mesotheliomas.
Hengge UR
Onkologie; 2008 Mar; 31(3):82. PubMed ID: 18322409
[No Abstract] [Full Text] [Related]
5. Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors.
Fu W; Lan H; Li S; Han X; Gao T; Ren D
Cancer Gene Ther; 2008 Jul; 15(7):474-84. PubMed ID: 18437183
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK.
Soghomonyan SA; Doubrovin M; Pike J; Luo X; Ittensohn M; Runyan JD; Balatoni J; Finn R; Tjuvajev JG; Blasberg R; Bermudes D
Cancer Gene Ther; 2005 Jan; 12(1):101-8. PubMed ID: 15499377
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Lee CH; Wu CL; Shiau AL
Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381
[TBL] [Abstract][Full Text] [Related]
8. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency.
Yoshikawa T; Niwa T; Mizuguchi H; Okada N; Nakagawa S
Gene Ther; 2008 Oct; 15(19):1321-9. PubMed ID: 18480845
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 model.
Fu W; Lan H; Liang S; Gao T; Ren D
Cancer Sci; 2008 Jun; 99(6):1172-9. PubMed ID: 18429958
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
[TBL] [Abstract][Full Text] [Related]
11. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models.
Luo X; Li Z; Lin S; Le T; Ittensohn M; Bermudes D; Runyab JD; Shen SY; Chen J; King IC; Zheng LM
Oncol Res; 2001; 12(11-12):501-8. PubMed ID: 11939414
[TBL] [Abstract][Full Text] [Related]
13. Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria-mediated tumour therapy in hosts with TNFR1 deficiency.
Xu W; Zhou T; Zhou J; Qiang Z; Zhang J; Hua Z
Lett Appl Microbiol; 2018 Jul; 67(1):97-103. PubMed ID: 29698572
[TBL] [Abstract][Full Text] [Related]
14. [Construction and characterization of delta crp delta asd mutant host-vector balanced lethal system of Salmonella choleraesuis C500 strain].
Xu YD; Guo AZ; Liu WH; Jia AQ; Chen HC
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):366-72. PubMed ID: 16755912
[TBL] [Abstract][Full Text] [Related]
15. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human mesothelioma cell lines as tumor models for suicide gene therapy.
Veldwijk MR; Berlinghoff S; Jauch A; Laufs S; Zeller WJ; Wenz F; Fruehauf S
Onkologie; 2008 Mar; 31(3):91-6. PubMed ID: 18322411
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation.
Thamm DH; Kurzman ID; King I; Li Z; Sznol M; Dubielzig RR; Vail DM; MacEwen EG
Clin Cancer Res; 2005 Jul; 11(13):4827-34. PubMed ID: 16000580
[TBL] [Abstract][Full Text] [Related]
18. Two oral HBx vaccines delivered by live attenuated Salmonella: both eliciting effective anti-tumor immunity.
Wang YJ; Hou Y; Huang H; Liu GR; White AP; Liu SL
Cancer Lett; 2008 May; 263(1):67-76. PubMed ID: 18226855
[TBL] [Abstract][Full Text] [Related]
19. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
20. Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model.
Jazowiecka-Rakus J; Szala S
Acta Biochim Pol; 2004; 51(3):851-6. PubMed ID: 15448746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
